Search Results - "G R Galstyan"

Refine Results
  1. 1

    The use of long-acting insulin degludec in adult patients with type 2 diabetes mellitus in real clinical practice in Russia by Galstyan, G. R.

    Published in Sakharnyĭ diabet (10-02-2023)
    “…BACKGROUND: Effective glycaemic control remains the most important task in managing the risks of Diabetes type 2 complications development. In this regard, the…”
    Get full text
    Journal Article
  2. 2

    Impact of various wound dressings on wound bed neoangiogenesis in patients with different forms of diabetic foot syndrome by E L Zaitseva, A Yu Tokmakova, L P Doronina, I A Voronkova, G R Galstyan, M V Shestakova

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…Aim. To investigate the impact of various wound dressings on wound bed neoangiogenesis in patients with different forms of diabetic foot syndrome (DFS)…”
    Get full text
    Journal Article
  3. 3

    Comparative evaluation of the intensity of reparative processes in the lower extremity soft tissues of diabetic patients receiving local negative pressure wound treatment and standard wound care by Galstyan, G R, Tokmakova, A Yu, Zaitseva, E L, Doronina, L P, Voronkova, I A, Molchkov, R V

    Published in Terapevtic̆eskii arhiv (01-01-2016)
    “…To study the intensity of soft tissue repair in patients with diabetic foot syndrome (DFS) during local negative pressure wound treatment versus standard wound…”
    Get full text
    Journal Article
  4. 4

    Features of diagnostics and treatments of the patient with type 2 diabetes mellitus and chronic ischtmia with threating lower limb loss by Bondarenko, O. N., Yaroslavceva, M. V., Galstyan, G. R., Larina, V. A., Petrosyan, A. S., Mokrysheva, N. G.

    Published in Sakharnyĭ diabet (06-05-2024)
    “…The article presents the result of our own observation of the patient with a poor control of type 2 diabetes mellitus (DM) for a long period, complicated by…”
    Get full text
    Journal Article
  5. 5

    Practical aspects of initiation and use of SGLT2 inhibitors: inpatient and outpatient perspectives by Salukhov, V. V., Galstyan, G. R., Ilyinskay, T. A.

    Published in Sakharnyĭ diabet (01-07-2022)
    “…In today`s therapy of type 2 diabetes mellitus, SGLT2 inhibitors have taken their rightful place both due to their positive hypoglycemic and outstanding…”
    Get full text
    Journal Article
  6. 6

    The role of glycation end products in the development and progression of diabetic neuroarthropathy by Kalandiya, M. M., Tokmakova, A. Yu, Galstyan, G. R.

    Published in Problemy ėndokrinologii (04-07-2021)
    “…Diabetic neuroarthropathy (DNOAP, Charcot’s foot) is a serious complication of diabetes mellitus, the genesis of which is not fully understood. In most cases,…”
    Get full text
    Journal Article
  7. 7

    Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federation by Vikulova, O. K., Galstyan, G. R., Shestakova, M. V.

    Published in Sakharnyĭ diabet (23-03-2022)
    “…RATIONALE. Over the past 20 years the prevalence of type 2 diabetes in Russia has more than doubled and reached 4.43 million people in 2020, while the growth…”
    Get full text
    Journal Article
  8. 8

    Influence of peripheral nerve system on proliferation and migration of keratinocytes on site of the wound edges by Artemova, E. V., Dzhemilova, Z. N., Gorbacheva, A. M., Galstyan, G. R., Tokmakova, A. Yu, Berdalin, A. B., Gavrilova, S. A.

    Published in Sakharnyĭ diabet (06-05-2024)
    “…AIM: to assess proliferation and migration of keratinocytes at the nonhealing edges of neuropathic wounds. MATERIALS AND METHODS : 25 patients with neuropathic…”
    Get full text
    Journal Article
  9. 9

    Humoral factors in the formation of neuroosteoarthropathy in type 2 diabetes mellitus by Kalandiya, M. M., Kogan, E. A., Nikankina, L. V., Tokmakova, A. Y., Zaitseva, E. L., Galstyan, G. R.

    Published in Sakharnyĭ diabet (01-12-2023)
    “…B ACKGROUND : Diabetic neuroosteoarthropathy is a severe and insufficiently studied complication of diabetes mellitus, which is characterized by progressive…”
    Get full text
    Journal Article
  10. 10

    Long-term results of corrective surgical interventions in patients with diabetic midfoot neuroosteoarthropathy by Kalandiya, M. M., Doronina, L. P., Mitish, V. A., Tokmakova, A. Yu, Zaitseva, E. L., Galstyan, G. R.

    Published in Sakharnyĭ diabet (01-11-2023)
    “…BACKGROUND : Diabetic neuroosteoarthropathy is a disabling complication of diabetes mellitus that develops as a result of impaired peripheral innervation and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Correction of Retrograde Ejaculation in Patients with Diabetes Mellitus Using Endourethral Collagen Injection: Preliminary Results by Kurbatov, Dmitry, Russo, Giorgio Ivan, Galstyan, G.R., Rozhivanov, Roman, Lepetukhin, Alexander, Dubsky, Sergey, Shwartz, Y.G., Cimino, Sebastiano, Morgia, Giuseppe, Sansalone, Salvatore

    Published in Journal of sexual medicine (01-11-2015)
    “…Diabetic neuropathy secondary to diabetes mellitus type 1 (DM1) is responsible for retrograde ejaculation (RE) in 5–18% of cases. Medical treatment of RE is…”
    Get full text
    Journal Article
  13. 13

    Clinical evaluation of the implementation of the first pilot Russian integrated program for an integrated approach to the management of diabetes mellitus “NORMA” by Galstyan, G. R., Mayorov, A. Y., Melnikova, O. G., Holmskaya, N. I., Hamradjanov, Z. A., Milyutin, V. I., Shestakova, M. V.

    Published in Sakharnyĭ diabet (10-02-2023)
    “…BACKGROUND : Despite progress in the treatment of patients with diabetes mellitus (DM), the problem of achieving target values of glycemic control remains…”
    Get full text
    Journal Article
  14. 14

    The role of neurohumoral factors in the persistence of aseptic bone inflammation in patients with diabetic neuroosteoarthropathy by Zaitseva, E. L., Kalandiya, M. M., Tokmakova, A. Yu, Malysheva, N. M., Nikankina, L. V., Galstyan, G. R.

    Published in Sakharnyĭ diabet (01-12-2022)
    “…BACKGROUND : Diabetic neuroosteoarthropathy (DNOAP, Charcot foot) is a relatively rare complication of diabetes mellitus (DM), which can lead not only to…”
    Get full text
    Journal Article
  15. 15

    National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus by Shestakova, M. V., Vagapova, G. R., Vikulova, O. K., Galstyan, G. R., Demidova, T. Yu, Dudinskaya, E. N., Kiseleva, T. P., Mkrtumyan, A. M., Petunina, N. A., Tkacheva, O. N., Fadeev, V. V., Khalimov, Y. S., Shestakova, E. A.

    Published in Sakharnyĭ diabet (06-12-2023)
    “…TThe annual increase in the prevalence of type 2 diabetes mellitus emphasizes the relevance of the search for new treatment options, along with necessity for…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Pancreatic exocrine insufficiency in diabetes mellitus by Shestakova, M. V., Maev, I. V., Ametov, A. S., Antsiferov, M. B., Bordin, D. S., Galstyan, G. R., Dzgoeva, F. K., Kucheryavyy, Y. A., Mkrtumyan, A. M., Nikonova, T. V., Pashkova, E. Y.

    Published in Sakharnyĭ diabet (21-05-2023)
    “…Diabetes is disease of both the endo- and exocrine parts of the pancreas. Pancreatic exocrine insufficiency (PEI) can occur in every 2–3 patients with diabetes…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Long-term Follow-up of treatment of chronic foot wounds with recombinant human epidermal growth factor in patients with different complications of diabetes mellitus by Zaitseva, E. L., Zhilyaev, V. M., Galstyan, G. R.

    Published in Sakharnyĭ diabet (01-01-2020)
    “…BACKGROUND : Diabetic foot ulcer (DFU) is a dangerous complication of diabetes mellitus (DM), which can lead to the development of chronic wounds and…”
    Get full text
    Journal Article